Guardado en:
Detalles Bibliográficos
Autores principales: Vijayakumara, Naveensubramaniam, IBulyginab, Inna, Lvovb, Vlad, Choudhary, Rajan, Venkatramana, Senthil Kumar, Senatovb, Fedor, Kaloshkinb, Sergey, Swamiappana, Sasikumar
Formato: Recurso digital
Lenguaje:inglés
Publicado: Zenodo 2022
Materias:
Acceso en línea:https://doi.org/10.5281/zenodo.15717331
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1866902194782994432
author Vijayakumara, Naveensubramaniam
IBulyginab, Inna
Lvovb, Vlad
Choudhary, Rajan
Venkatramana, Senthil Kumar
Senatovb, Fedor
Kaloshkinb, Sergey
Swamiappana, Sasikumar
author_facet Vijayakumara, Naveensubramaniam
IBulyginab, Inna
Lvovb, Vlad
Choudhary, Rajan
Venkatramana, Senthil Kumar
Senatovb, Fedor
Kaloshkinb, Sergey
Swamiappana, Sasikumar
contents <p>Release kinetics of a drug from the ceramic drug delivery carrier depends on various parameters such as nature of<br>the ceramic, binder, porosity of the ceramics, particle size of the ceramic and, solubility as well as nature of the<br>drug. In the present study effect of formulation on the release kinetics of the drug from hydroxyapatite, the carrier<br>was studied. Hydroxyapatite and Zirconia were taken as ceramic carriers and the model drugs taken for comparison<br>are ciprofloxacin hydrochloride and levofloxacin whereas polyvinyl alcohol was added as a binder. Ciprofloxacin<br>hydrochloride shows a sustained release whereas levofloxacin shows burst release from the ceramic drug carrier.<br>The percentage of polyvinyl alcohol added to the drug played a vital role as a higher concentration of the polymer<br>affects the stability of the drug carrier. Hydroxyapatite/zirconia composite shows sustained release (29%) when<br>compared to pure hydroxyapatite (43%) and zirconia (37%) after 6 hours of immersion in simulated body fluid.<br>Release kinetics shows that the solubility of the drug, concentration of the binder, and the ratio of ceramics in the<br>composites decides the release kinetics of the drug from the drug delivery carrier.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_15717331
institution Zenodo
language eng
publishDate 2022
publisher Zenodo
record_format zenodo
spellingShingle Effect of Formulation on the Release Kinetics of the Antibiotics from Biocompatible Ceramics
Vijayakumara, Naveensubramaniam
IBulyginab, Inna
Lvovb, Vlad
Choudhary, Rajan
Venkatramana, Senthil Kumar
Senatovb, Fedor
Kaloshkinb, Sergey
Swamiappana, Sasikumar
hydroxyapatite, seashells, composite scaffold, bone tissue engineering
<p>Release kinetics of a drug from the ceramic drug delivery carrier depends on various parameters such as nature of<br>the ceramic, binder, porosity of the ceramics, particle size of the ceramic and, solubility as well as nature of the<br>drug. In the present study effect of formulation on the release kinetics of the drug from hydroxyapatite, the carrier<br>was studied. Hydroxyapatite and Zirconia were taken as ceramic carriers and the model drugs taken for comparison<br>are ciprofloxacin hydrochloride and levofloxacin whereas polyvinyl alcohol was added as a binder. Ciprofloxacin<br>hydrochloride shows a sustained release whereas levofloxacin shows burst release from the ceramic drug carrier.<br>The percentage of polyvinyl alcohol added to the drug played a vital role as a higher concentration of the polymer<br>affects the stability of the drug carrier. Hydroxyapatite/zirconia composite shows sustained release (29%) when<br>compared to pure hydroxyapatite (43%) and zirconia (37%) after 6 hours of immersion in simulated body fluid.<br>Release kinetics shows that the solubility of the drug, concentration of the binder, and the ratio of ceramics in the<br>composites decides the release kinetics of the drug from the drug delivery carrier.</p>
title Effect of Formulation on the Release Kinetics of the Antibiotics from Biocompatible Ceramics
topic hydroxyapatite, seashells, composite scaffold, bone tissue engineering
url https://doi.org/10.5281/zenodo.15717331